HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dirk Geerts Selected Research

Dirk Geerts Research Topics

Disease

34Neoplasms (Cancer)
01/2022 - 11/2007
19Neuroblastoma
01/2019 - 11/2007
7Breast Neoplasms (Breast Cancer)
01/2021 - 10/2014
5Carcinogenesis
01/2022 - 01/2014
5Inflammation (Inflammations)
01/2019 - 06/2012
5Neoplasm Metastasis (Metastasis)
01/2018 - 10/2014
4Glioblastoma (Glioblastoma Multiforme)
11/2016 - 09/2010
2Neuroinflammatory Diseases
01/2019 - 06/2012
2Astrocytoma (Pilocytic Astrocytoma)
07/2014 - 07/2014
2Glioma (Gliomas)
07/2014 - 07/2010
2Leukemia
08/2013 - 01/2013
2Multiple Sclerosis
02/2013 - 06/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Endometrial Neoplasms (Endometrial Cancer)
01/2022
1Adenocarcinoma
12/2021
1Atrioventricular Block
01/2020
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Bradycardia
01/2020
1Virus Diseases (Viral Diseases)
01/2019
1Rheumatoid Arthritis
01/2019
1Ulcerative Colitis
01/2019
1Ischemia
09/2018
1Necrosis
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2017
1Starvation
11/2016
1Obesity
01/2016
1Insulin Resistance
01/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Triple Negative Breast Neoplasms
10/2014

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2007
14Messenger RNA (mRNA)IBA
12/2021 - 11/2007
8PolyaminesIBA
01/2022 - 05/2010
5Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2008
4SpermidineIBA
01/2022 - 12/2014
4Pharmaceutical PreparationsIBA
01/2019 - 08/2009
4Eflornithine (Ornidyl)FDA Link
11/2018 - 04/2013
4Phosphotransferases (Kinase)IBA
01/2018 - 01/2010
4Small Interfering RNA (siRNA)IBA
01/2017 - 09/2014
3AntigensIBA
01/2022 - 01/2003
3OsteoprotegerinIBA
01/2020 - 10/2014
3Protein Isoforms (Isoforms)IBA
01/2019 - 07/2014
3Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
01/2018 - 05/2010
2hypusineIBA
01/2022 - 01/2018
2CytokinesIBA
01/2022 - 01/2017
2Peptides (Polypeptides)IBA
01/2022 - 06/2012
2Biological ProductsIBA
01/2020 - 12/2011
2TNF-Related Apoptosis-Inducing LigandIBA
01/2020 - 10/2014
2Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2019 - 06/2015
2EnzymesIBA
01/2019 - 01/2018
2Annexin A5IBA
01/2018 - 11/2007
2CationsIBA
01/2018 - 09/2014
2LigandsIBA
01/2017 - 03/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 02/2013
2sepiapterin reductaseIBA
06/2015 - 01/2014
2PlectinIBA
07/2014 - 01/2003
1homeobox A1 proteinIBA
01/2022
1Chimeric Antigen ReceptorsIBA
01/2022
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2022
1InterleukinsIBA
01/2022
1Calcibiotic Root Canal SealerIBA
01/2022
1Peptide Initiation Factors (Initiation Factor)IBA
01/2022
1cytidylyl-(3'-5')-cytidine (CpC)IBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1SodiumIBA
01/2020
1ChemokinesIBA
01/2020
1Poly I-CIBA
01/2019
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2019
1NADPH Oxidases (NAD(P)H oxidase)IBA
09/2018
1Drug CombinationsIBA
01/2018
1CaspasesIBA
01/2018
1Harmine (Telepathine)IBA
01/2018
1GlycosyltransferasesIBA
01/2018
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2018
1Calcium Channels (Calcium Channel)IBA
01/2018
1CC ChemokinesIBA
01/2017
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2017
1Monocyte Chemoattractant ProteinsIBA
01/2017
1Complementary DNA (cDNA)IBA
01/2017
1von Willebrand FactorIBA
01/2017
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2017
1Polysaccharides (Glycans)IBA
02/2016
1N-Acetylneuraminic Acid (Sialic Acid)IBA
02/2016
1sialic acid transport proteinsIBA
02/2016
1Myeloid Ecotropic Viral Integration Site 1 ProteinIBA
02/2016
1Amino AcidsFDA Link
02/2016
1LeptinIBA
01/2016
1Triglycerides (Triacylglycerol)IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1Fatty Acids (Saturated Fatty Acids)IBA
01/2016
1Caveolin 1IBA
01/2016
1SpermineIBA
06/2015
1N(1)-guanyl-1,7-diaminoheptaneIBA
12/2014
1deoxyhypusine synthaseIBA
12/2014

Therapy/Procedure

12Therapeutics
01/2022 - 08/2009
3Drug Therapy (Chemotherapy)
01/2018 - 08/2013
2Combined Modality Therapy
06/2015 - 12/2014
1Immunotherapy
01/2022
1Radiotherapy
11/2016